Menarini Forms Antibody-Based Drug Alliance with Oxford BioTherapeutics
By Heather Cartwright
Pharma Deals Review: Vol 2012 Issue 11 (Table of Contents)
Published: 12 Nov-2012
DOI: 10.3833/pdr.v2012.i11.1835 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Menarini has partnered with Oxford BioTherapeutics (OBT) to develop a portfolio of antibody-based drugs in the field of cancer...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS